Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer. - Eisses B; van Geel JJL; Brouwers AH; Bensch F; Elias SG; Kuip EJM; Jager A; van der Vegt B; Lub-de Hooge MN; Emmering J; Arens AIJ; Zwezerijnen GJC; et al. (Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024)